Category: PRESS RELEASES

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody

Read More....

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to

Read More....

UPDATE — VERSES, DENTONS US and SWF, Announce Collaboration on Landmark Industry Report “A Path to Global AI Governance”

Figure 1 VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE CANADA:VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in the next generation of artificial intelligence (“AI”), announces the release in June 2023 of an AI industry report titled “THE ROAD TO AUTONOMY:

Read More....

Delmar Expands Operations into Pakistan and Sri Lanka

Delmar Indian Subcontinent Map MONTREAL, June 05, 2023 (GLOBE NEWSWIRE) — Delmar International Inc. (www.delmarcargo.com), a world-renowned leader in logistics and supply chain solutions, expands into the dynamic markets of Pakistan and Sri Lanka. This strategic move further signifies Delmar’s commitment to providing leading global logistics and supply chain solutions

Read More....

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets Lotus Pharmaceuticals will acquire worldwide rights for NRX-101 for S-TRBD and will be responsible for commercialization of NRX-101 in markets outside the US through Lotus’s

Read More....

Btab Ecommerce Group, Inc. (formerly American Seniors Association Holding Group, Inc.) Announces Name Change and OTC Markets Ticker Symbol Change

Effective at the Open of Market Trading Today, the Company Began Trading as Btab Ecommerce Group, Inc. (OTC: BBTT) SYDNEY, Australia, June 05, 2023 (GLOBE NEWSWIRE) — Btab Ecommerce Group, Inc., a Georgia Corporation (the “Company”), announced that at the open of market trading today, June 5, 2023, its trading name on

Read More....